Net Cash Provided by (Used in) Operating Activities |
-264M |
USD |
-198% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-29.3M |
USD |
+90.7% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
700M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
456M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-294M |
USD |
-580% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
274M |
USD |
-5.97% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
8.58M |
USD |
-57.8% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
140M |
USD |
+20% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
3.19B |
USD |
-0.66% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Interest Expense |
20.2M |
USD |
-63% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |